10-Q/A

AMENDED QUARTERLY REPORT

Company: Lineage Cell Therapeutics, Inc.
Filed: November 16, 2001
Period of Report: September 30, 2001
Accession Number: 0000891554-01-506422

View Document ↗ View on SEC.gov ↗